Albendazole Suppresses SARS‐CoV‐2 Replication by Enhancing HERC5‐Mediated ISGylation of Nucleocapsid Protein
Journal of Medical Virology · 2025-12 · 97 (12)
DOI: 10.1002/jmv.70751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 17.12.2025. Verfasst von Yezi Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital,…. Hauptthemen laut MEDLINE: Albendazole, Ubiquitin-Protein Ligases, Ubiquitins, COVID-19 Drug Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Key R&D Program of China, National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China.
Abstract (Originalsprache)
Interferons constitute the host's primary antiviral defense system. It causes the expression of interferon‐stimulated genes (ISGs), including ISG15, which modulate viral replication. Here, we identify the E3 ligase HERC5—a crucial mediator of ISGylation—as an antiviral factor against SARS‐CoV‐2. Analysis using mass spectrometry showed that the viral nucleocapsid (N) protein is directly bound by HERC5, which then catalyzes ISGylation occurs at four lysine residues‐K61, K65, K102, and K355‐found in the NTD and CTD. Functional assays confirmed that ISGylation at these sites disrupts the N protein's capacity for RNA binding and oligomerization. Conversely, the papain‐like protease (PLpro) of SARS‐CoV‐2 cleaves ISG15 conjugates, thereby reversing N protein ISGylation. To discover small molecules that enhance the “HERC5‐N” interaction, we developed a NanoLuc luciferase‐based screening platform and evaluated 1815 FDA‐approved drugs. Albendazole emerged as a potent enhancer of “HERC5‐N” binding, further promoted N protein ISGylation, and inhibited viral replication. In vivo, Albendazole treatment reduced viral load and alleviated pulmonary inflammation in a transgenic mouse model of K18‐hACE2. Together, these findings reveal the crucial functionality of N protein ISGylation in SARS‐CoV‐2 replication and highlight HERC5‐mediated ISGylation as a promising therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Sh…
- Department of Clinical Laboratory, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China.
- Department of Microbiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, China.
ORCID-Profile: Zheng Zhang
Förderung
- National Key R&D Program of China
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- Major Project of Guangzhou National Laboratory
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Science and Technology Program
Zitieren
APA
Wu, Y., Yang, C., Wei, X., Xiao, T., Zhou, J., Fan, L., Gao, X., Shen, X., He, X., Xu, G., Liu, L., Zhou, Y., & Zhang, Z. (2025). Albendazole Suppresses SARS‐CoV‐2 Replication by Enhancing HERC5‐Mediated ISGylation of Nucleocapsid Protein. Journal of Medical Virology, 97(12). https://doi.org/10.1002/jmv.70751
Vancouver
Wu Y, Yang C, Wei X, Xiao T, Zhou J, Fan L, et al. Albendazole Suppresses SARS‐CoV‐2 Replication by Enhancing HERC5‐Mediated ISGylation of Nucleocapsid Protein. Journal of Medical Virology. 2025;97(12). doi:10.1002/jmv.70751
BibTeX
@article{Wu2025,
author = {Wu, Yezi and Yang, Chuwei and Wei, Xiafei and Xiao, Tongyang and Zhou, Jian and Fan, Lujie and Gao, Xiang and Shen, Xiaotong and He, Xiaomeng and Xu, Gang and Liu, Lei and Zhou, Yuzheng and Zhang, Zheng},
title = {Albendazole Suppresses SARS‐CoV‐2 Replication by Enhancing HERC5‐Mediated ISGylation of Nucleocapsid Protein},
journal = {Journal of Medical Virology},
year = {2025},
volume = {97},
number = {12},
doi = {10.1002/jmv.70751}
}
EUVIMED